Skip to main content
. 2020 Apr 17;8(2):118–124. doi: 10.4103/sjmms.sjmms_272_19

Table 1.

Distribution of patients according to the cause of chronic liver disease (n = 494)

Diagnosis Number of patients (%)
NAFLD 111 (22.5)
CHB 166 (33.6)
CHC 153 (31)
AIH 30 (6.1)
Methotrexate 19 (3.8)
Chronic cholestasis of unknown etiology 1 (0.2)
Overlap syndrome 4 (0.8)
PBC 3 (0.6)
CHB + CHC 6 (1.2)
AIH due to DILI 1 (0.2)

NAFLD – Nonalcoholic fatty liver disease; CHB – Chronic hepatitis B; CHC – Chronic hepatitis C; PBC – Primary biliary cholangitis; AIH – Autoimmune hepatitis; DILI – Drug-induced liver injury